Form D · Other
NANO PHARMACEUTICAL LABORATORIES LLC
Centennial, CO · CIK 0001552264
Offering snapshot reported Jan 8, 2016 · SEC filing
- Reported sold
- $1.2M Offering amount: $4.26M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $23.8K Reported outside-investor minimum
- First sale
- Aug 14, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2016 | Initial | $1,200,000 | No comparison | 6 | SEC filing |
| Jun 19, 2014 | Initial | $1,500,000 | No comparison | 20 | SEC filing |
| Jun 19, 2012 | Initial | $250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06c, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $60K
- Finders' fees
- $0
- Form D file number
- 021-254787
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| FUNDME SECURITIES LLC | 161785 |
Source: Form D, filed Jan 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Niichel | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
7308 South Alton Way 2 G
Centennial, CO, 80112
Centennial, CO, 80112